CarolRSchermerMDMPH, FACS

PubMed

• 12 citations
  Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis.
  Greta Lozano-Ortega, David Walker, Karissa Johnston, A. Mickle, Sean Harrigan, Basia Rogula, Rita M Kristy, John Hairston, Carol R. Schermer> ;Drugs & Aging. 2020 Sep 22
• 10 citations
  Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overact...
  Sender Herschorn, David R. Staskin, Carol R. Schermer, Rita M Kristy, Adrian Wagg> ;Drugs & Aging. 2020 Sep 1
• 1 citations
  Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries
  Rajender R. Aparasu, S.D. Sura, J.R. Earla, Aki Shiozawa, Daniel B. Ng, Carol R. Schermer> ;Advances in Therapy. 2020 Jul 7
• 8 citations
  Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder.
  Greta Lozano-Ortega, Carol R. Schermer, David Walker, Shelagh M. Szabo, Basia Rogula, Alison Deighton, Katherine Gooch, Noll L. Campbell> ;Pharmacoeconomics - Open. 2021 Mar 1
• 43 citations
  Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)
  Tomas L. Griebling, Noll L. Campbell, Jeffrey Mangel, David R. Staskin, Sender Herschorn, Dina Elsouda, Carol R. Schermer> ;BMC Geriatrics. 2020 Mar 18
• 27 citations
  Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasi...
  Steven A. Kaplan, Sender Herschorn, Kevin T. McVary, David R. Staskin, Christopher R. Chapple, Steve Foley, Javier Cambronero Santos, Rita M Kristy, Nurul Choudhury, J...> ;The Journal of Urology. 2020 Jan 2
• 44 citations
  Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (P...
  Adrian Wagg, David R. Staskin, Eli Engel, Sender Herschorn, Rita M Kristy, Carol R. Schermer> ;European Urology. 2020 Feb 1
• 10 citations
  Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSP...
  Kevin V. Carlson, Eric S. Rovner, Kavita V. Nair, Anna S. Deal, Rita M Kristy, Carol R. Schermer> ;Advances in Therapy. 2019 Jun 20
• 51 citations
  Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
  Shelagh M. Szabo, Katherine Gooch, Carol R. Schermer, David Walker, Greta Lozano-Ortega, Basia Rogula, Alison Deighton, Edward F. Vonesh, Noll L. Campbell> ;BMJ Open. 2019 May 5
• 15 citations
  Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome.
  William B. White, Emad Siddiqui, Tri Tat, Billy Franks, Carol R. Schermer> ;Journal of the American Society of Hypertension. 2018 Nov 1
• 3 citations
  A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology.
  Eric S. Rovner, Kevin V. Carlson, Anna S. Deal, Kavita V. Nair, Eva Erber Oakkar, Julie Park, Eric Gemmen, Rita M Kristy, Katherine Gooch, Carol R. Schermer> ;Contemporary Clinical Trials. 2018 May 16
• 10 citations
  Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover,...
  Sender Herschorn, David R. Staskin, Le Mai Tu, Jonathan Fialkov, Terry Walsh, Katherine Gooch, Carol R. Schermer> ;Health and Quality of Life Outcomes. 2018 Apr 19
• 4 citations
  Impact of Fluid Choice in Systemic Inflammatory Response Syndrome Patients on Hospital Cost Savings
  Suzanne Laplante, D Makhija, Sibyl H. Munson, VS Khangulov, F.W. Peyerl, Scott M. Paluszkiewicz, AJ Ravindranath, Carol R. Schermer> ;Pharmacoeconomics - Open. 2018 Sep 1
• 25 citations
  A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in ...
  David R. Staskin, Sender Herschorn, Jonathan Fialkov, Le Mai Tu, Terry Walsh, Carol R. Schermer> ;International Urogynecology Journal. 2018 Feb 1
• 3 citations
  A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instru...
  Suvapun Bunniran, Cralen Davis, Rita M Kristy, Daniel Ng, Carol R. Schermer, Claudia Uribe, Brandon T. Suehs> ;Neurourology and Urodynamics. 2018 Jan 1
• 7 citations
  Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members.
  Ibrahim M Abbass, Eleanor O. Caplan, Daniel B. Ng, Rita M Kristy, Carol R. Schermer, Pamela Bradt, Jenna Collins, Wai Man Maria Chan, Brandon T. Suehs> ;Journal of Managed Care & Specialty Pharmacy. 2017 Jan 1
• 20 citations
  A randomized trial of Plasma-Lyte A and 0.9 % sodium chloride in acute pediatric gastroenteritis
  Coburn H. Allen, Ran D. Goldman, Seema Bhatt, Harold K. Simon, Marc H. Gorelick, Philip R. Spandorfer, David M. Spiro, Sharon E. Mace, David W. Johnson, Eric Higginbot...> ;BMC Pediatrics. 2016 Aug 2
• 21 citations
  Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
  Andrew D Shaw, Carol R Schermer, Dileep N Lobo, Sibyl H Munson, Victor Khangulov, David K Hayashida, John A Kellum> ;Critical Care. 2016 Jan 20
• 13 citations
  Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
  Andrew D Shaw, Carol R Schermer, Dileep N Lobo, Sibyl H Munson, Victor Khangulov, David K Hayashida, John A Kellum> ;Critical Care. 2015 Sep 12
• 17 citations
  Does saline resuscitation affect mechanisms of coagulopathy in critically ill trauma patients? An exploratory analysis.
  Caitlin A. Smith, Robert C. Gosselin, Garth H. Utter, Joseph M. Galante, Jason B. Young, Lynette A. Scherer, Carol R. Schermer> ;Blood Coagulation & Fibrinolysis. 2015 Apr 1
• 198 citations
  Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation.
  M. L. Krajewski, Karthik Raghunathan, Scott M. Paluszkiewicz, Carol R. Schermer, Andrew D. Shaw> ;The British Journal of Surgery. 2014 Oct 30
• 141 citations
  Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS
  Andrew D. Shaw, Karthik Raghunathan, F.W. Peyerl, Sibyl H. Munson, Scott M. Paluszkiewicz, Carol R. Schermer> ;Intensive Care Medicine. 2014 Oct 8
• 35 citations
  Use of ketorolac is associated with decreased pneumonia following rib fractures.
  Yifan Yang, Jason B. Young, Carol R. Schermer, Garth H. Utter> ;American Journal of Surgery. 2014 Apr 1
• 21 citations
  Cost-minimization analysis of two fluid products for resuscitation of critically injured trauma patients
  Caitlin A. Smith, Jeremiah J. Duby, Garth H. Utter, Joseph M. Galante, Lynette A. Scherer, Carol R. Schermer> ;American Journal of Health-System Pharmacy. 2014 Mar 15
• 6 citations
  The effect on problematic drinking behavior of a brief motivational interview shortly after a first arrest for driving under the influence of alcohol: a randomized trial.
  Garth H. Utter, Jason B. Young, Leslie A. Theard, David M. Cropp, Craig J. Mohar, Daniel Eisenberg, Carol R. Schermer, Leon J. Owens> ;The Journal of Trauma and Acute Care Surgery. 2014 Mar 1
• Join now to see all